Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Clinical trial NCT06925594 · RECRUITING

Trial details

NCT number: NCT06925594
Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2025-03-20
Primary completion: 2026-12-28
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.